Alignment EVP sells 25K shares under 10b5-1 plan
Alignment Healthcare, Inc. executive Joseph S. Konowiecki, EVP of Corporate Affairs and a director, reported an open-market sale of 25,000 shares of Common Stock at $23.00 per share.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
Alignment Healthcare, Inc. executive Joseph S. Konowiecki, EVP of Corporate Affairs and a director, reported an open-market sale of 25,000 shares of Common Stock at $23.00 per share. The transaction was made pursuant to a Rule 10b5-1 trading plan adopted on 03/04/2026, indicating it was pre-arranged. After the sale, he directly owns 1,128,816 shares, so the transaction represents a relatively small portion of his overall holdings.
Insider Trade Summary 10b5-1
Net Seller: 25,000 shares
Net Sell
1 txn
Insider
KONOWIECKI JOSEPH S
Role
EVP, Corporate Affairs
Sold
25,000 shs ($575K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 25,000 | $23.00 | $575K |
Holdings After Transaction:
Common Stock — 1,128,816 shares (Direct)
Footnotes (1)
- F1. Date of Rule 10b5-1 plan adoption: 03/04/2026
Key Figures
Shares sold: 25,000 shares
Sale price: $23.00 per share
Shares held after transaction: 1,128,816 shares
+1 more
4 metrics
Shares sold
25,000 shares
Open-market sale of Common Stock
Sale price
$23.00 per share
Price for the 25,000-share sale
Shares held after transaction
1,128,816 shares
Direct ownership following the sale
Rule 10b5-1 plan adoption date
03/04/2026
Trading plan covering the reported sale
Key Terms
Rule 10b5-1 plan, open-market sale, Common Stock, Form 4
4 terms
Rule 10b5-1 plan regulatory
"Date of Rule 10b5-1 plan adoption: 03/04/2026"
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.
open-market sale financial
"transaction_action: "open-market sale" for the Common Stock"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
Common Stock financial
"security_title: "Common Stock" in the reported transaction"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
Form 4 regulatory
"INSIDER FILING DATA (Form 4) for Alignment Healthcare, Inc."
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Alignment Healthcare (ALHC) insider Joseph Konowiecki do in this Form 4?
Joseph S. Konowiecki reported selling 25,000 shares of Alignment Healthcare Common Stock at $23.00 per share. He is EVP of Corporate Affairs and a director, and the sale was executed as an open-market transaction under a pre-arranged Rule 10b5-1 trading plan.
Was the Alignment Healthcare (ALHC) insider sale under a Rule 10b5-1 plan?
Yes. The filing notes a Rule 10b5-1 trading plan adopted on 03/04/2026. The 25,000-share open-market sale at $23.00 per share was executed under this pre-arranged plan, which typically indicates a scheduled, rather than opportunistic, transaction.
What type of transaction is reported for Alignment Healthcare (ALHC) in this Form 4?
The Form 4 reports a non-derivative transaction in Common Stock with code “S,” meaning an open-market or private sale. It involves 25,000 shares sold at $23.00 per share, reducing but not eliminating Joseph S. Konowiecki’s significant remaining direct holdings.
Who is the insider involved in the Alignment Healthcare (ALHC) Form 4 filing?
The insider is Joseph S. Konowiecki, who serves as EVP of Corporate Affairs and a director at Alignment Healthcare. He reported a Rule 10b5-1 plan-based open-market sale of 25,000 shares at $23.00 per share, leaving him with 1,128,816 directly held shares.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates